Urolithin oral care compositions patent application
Summary
USPTO published patent application US20260090966A1 for urolithin-based oral care compositions including toothpaste, mouthwash, gels, and chewing gum with therapeutic or cosmetic effects. The application covers compositions comprising urolithins, methods of treatment, and formulations with additional active ingredients such as fluoride. Inventors include Christopher L. Rinsch, Davide D'Amico, Anurag Singh, and Charlotte Tissot.
What changed
USPTO published patent application US20260090966A1 on April 2, 2026, covering compositions comprising urolithins for oral care applications. The application (originally filed August 1, 2025 as Application No. 19288549) includes claims for toothpaste, gels, mouthwash, mouth rinses, mouth sprays, dental floss/tape, dental strips, dental sticks, and chewing gum. The compositions may include additional active ingredients such as fluoride and are directed to therapeutic or cosmetic effects in the oral cavity including teeth, gums, cheek, and tongue.
This is a published patent application, not a granted patent or regulatory requirement. Compliance teams should note this as potential future IP landscape consideration. Legal and R&D teams may want to review for freedom-to-operate analysis. No immediate action required unless the company is developing urolithin-based oral care products, in which case this application may affect patent strategy.
What to do next
- Review patent claims for potential infringement on urolithin oral care compositions
- Assess freedom-to-operate for any existing or planned oral care product lines
- Monitor USPTO for patent prosecution updates and potential claims amendments
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
UROLITHIN COMPOSITIONS
Application US20260090966A1 Kind: A1 Apr 02, 2026
Inventors
Christopher L. Rinsch, Davide D'Amico, Anurag Singh, Charlotte Tissot
Abstract
The invention relates to compositions comprising urolithins, specifically oral care compositions which have a therapeutic or cosmetic effect in the oral cavity, for example, the teeth, gums cheek, tongue etc. Such oral compositions include, toothpaste and gels, mouthwash, mouth rinses and mouth sprays and other oral care products, such as dental floss/tape, dental strips, dental sticks and chewing gum. The invention further comprises oral compositions comprising further active ingredients, for example, fluoride. The invention further comprises methods of using such compositions and formulations in the treatment of conditions and diseases and for cosmetic uses and processes for the preparation of such compositions. The invention also comprising methods of reducing the toxic effects of additives to oral composition, such as fluoride.
CPC Classifications
A61K 8/498 A61K 8/21 A61K 8/22 A61K 8/24 A61K 8/25 A61K 8/27 A61K 8/34 A61K 8/73 A61K 8/9789 A61K 31/366 A61P 1/02 A61P 29/00 A61Q 11/00 A61K 2800/28
Filing Date
2025-08-01
Application No.
19288549
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.